180 related articles for article (PubMed ID: 19663564)
21. Non-integrating lentiviral vectors for specific killing of Epstein-Barr virus nuclear antigen 1-positive B cell lymphoma cells.
Flynn RP; Zacharias J; Zhou X; Cannon ML; Philpott NJ
J Gene Med; 2011 Sep; 13(9):487-96. PubMed ID: 21850667
[TBL] [Abstract][Full Text] [Related]
22. The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.
Ariyoshi Y; Watanabe M; Eikawa S; Yamazaki C; Sadahira T; Hirata T; Araki M; Ebara S; Nasu Y; Udono H; Kumon H
Gene Ther; 2016 May; 23(5):408-14. PubMed ID: 26836118
[TBL] [Abstract][Full Text] [Related]
23. Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.
Lapteva N; Aldrich M; Weksberg D; Rollins L; Goltsova T; Chen SY; Huang XF
J Immunother; 2009; 32(2):145-56. PubMed ID: 19238013
[TBL] [Abstract][Full Text] [Related]
24. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.
Daenthanasanmak A; Salguero G; Borchers S; Figueiredo C; Jacobs R; Sundarasetty BS; Schneider A; Schambach A; Eiz-Vesper B; Blasczyk R; Weissinger EM; Ganser A; Stripecke R
Vaccine; 2012 Jul; 30(34):5118-31. PubMed ID: 22691433
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
Bryson PD; Han X; Truong N; Wang P
Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248
[TBL] [Abstract][Full Text] [Related]
26. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
[TBL] [Abstract][Full Text] [Related]
27. Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine.
Coutant F; Frenkiel MP; Despres P; Charneau P
PLoS One; 2008; 3(12):e3973. PubMed ID: 19096527
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice.
Willis RA; Bowers WJ; Turner MJ; Fisher TL; Abdul-Alim CS; Howard DF; Federoff HJ; Lord EM; Frelinger JG
Hum Gene Ther; 2001 Oct; 12(15):1867-79. PubMed ID: 11589829
[TBL] [Abstract][Full Text] [Related]
29. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy.
Morante V; Borghi M; Farina I; Michelini Z; Grasso F; Gallinaro A; Cecchetti S; Di Virgilio A; Canitano A; Pirillo MF; Bona R; Cara A; Negri D
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672349
[TBL] [Abstract][Full Text] [Related]
30. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Todo T; Martuza RL; Dallman MJ; Rabkin SD
Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
[TBL] [Abstract][Full Text] [Related]
31. Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
Odegard JM; Kelley-Clarke B; Tareen SU; Campbell DJ; Flynn PA; Nicolai CJ; Slough MM; Vin CD; McGowan PJ; Nelson LT; Ter Meulen J; Dubensky TW; Robbins SH
J Immunother; 2015; 38(2):41-53. PubMed ID: 25658613
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
[TBL] [Abstract][Full Text] [Related]
33. In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
Cayeux S; Bukarica B; Buschow C; Charo J; Bunse M; Dörken B; Blankenstein T
Gene Ther; 2007 Oct; 14(20):1481-91. PubMed ID: 17700709
[TBL] [Abstract][Full Text] [Related]
34. A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.
Buffa V; Negri DRM; Leone P; Bona R; Borghi M; Bacigalupo I; Carlei D; Sgadari C; Ensoli B; Cara A
J Gen Virol; 2006 Jun; 87(Pt 6):1625-1634. PubMed ID: 16690927
[TBL] [Abstract][Full Text] [Related]
35. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.
Luis A
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003492
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo.
Dresch C; Edelmann SL; Marconi P; Brocker T
J Immunol; 2008 Oct; 181(7):4495-506. PubMed ID: 18802052
[TBL] [Abstract][Full Text] [Related]
38. Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells.
Negri DR; Bona R; Michelini Z; Leone P; Macchia I; Klotman ME; Salvatore M; Cara A
Hum Gene Ther; 2010 Aug; 21(8):1029-35. PubMed ID: 20210625
[TBL] [Abstract][Full Text] [Related]
39. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors.
Mandl S; Hix L; Andino R
J Virol; 2001 Jan; 75(2):622-7. PubMed ID: 11134275
[TBL] [Abstract][Full Text] [Related]
40. Lentiviral vector induces high-quality memory T cells via dendritic cells transduction.
Ku MW; Authié P; Nevo F; Souque P; Bourgine M; Romano M; Charneau P; Majlessi L
Commun Biol; 2021 Jun; 4(1):713. PubMed ID: 34112936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
